Reportable Segment — Other segment items
Business Segments · Other segment itemsEli Lilly Reportable Segment — Other segment items decreased by 15.2% to $1.82B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 68.1%, from $1.08B to $1.82B. Over 3 years (FY 2022 to FY 2025), Reportable Segment — Other segment items shows an upward trend with a 76.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryOther
SignalLower is better
VolatilityVolatile
First reportedQ1 2022
Last reportedQ4 2025
How to read this metric
High volatility or large values may indicate non-recurring events or accounting adjustments that obscure underlying operational performance.
Detailed definition
Encompasses miscellaneous income or expense items specific to the segment that do not fall under standard operating cate...
Peer comparison
Comparable to 'other operating income/expense' lines in segment-level financial disclosures.
Metric ID:
lly_segment_reportable_segment_other_segment_itemsHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $281.78M | $281.78M | $281.78M | $281.78M | $321.30M | $321.30M | $321.30M | $321.30M | $266.10M | $1.18B | $637.70M | $1.08B | $970.80M | $1.21B | $2.15B | $1.82B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +14.0% | +0.0% | +0.0% | +0.0% | -17.2% | +344.5% | -46.1% | +69.8% | -10.4% | +24.3% | +78.0% | -15.2% |
| YoY Change | — | — | — | — | +14.0% | +14.0% | +14.0% | +14.0% | -17.2% | +268.1% | +98.5% | +237.1% | +264.8% | +2.0% | +236.8% | +68.1% |
Range$266.10M – $2.15B
CAGR+64.5%
Avg YoY Growth+101.2%
Median YoY Growth+41.1%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's reportable segment — other segment items?
- Eli Lilly (LLY) reported reportable segment — other segment items of $1.82B in Q4 2025.
- How has Eli Lilly's reportable segment — other segment items changed year-over-year?
- Eli Lilly's reportable segment — other segment items increased by 68.1% year-over-year, from $1.08B to $1.82B.
- What is the long-term trend for Eli Lilly's reportable segment — other segment items?
- Over 3 years (2022 to 2025), Eli Lilly's reportable segment — other segment items has grown at a 76.0% compound annual growth rate (CAGR), from $1.13B to $6.15B.
- What does reportable segment — other segment items mean?
- Miscellaneous income or expenses unique to this segment that are not part of core operations.